Major Players - Anti-inflammatory Drugs Industry

Anti-inflammatory drugs are prescribed frequently to treat pain, lessen inflammation, and lower a high body temperature. They are frequently employed to treat headache symptoms at difficult times. These medications are used to cure fever, lessen inflammation, and relieve discomfort. Worldwide, these medications are prescribed as well as used off-label in tablet, capsule, cream, liquid, injectable, spray, and suppository forms. Furthermore, growing occurrence of acute and chronic illnesses is anticipated to lift the growth of the market. The global market for anti-inflammatory medications is anticipated to rise as a result of ongoing research and development. In North America, rising rates of acute and chronic disorders are anticipated to spur market expansion.

The projected period (2020–2027) stipulates a CAGR of 8.6% for the worldwide Anti-Inflammatory Drugs market.

Top Companies in the Anti-inflammatory Drugs Industry:

Pfizer, Inc.

Pfizer, Inc. is an American multinational pharmaceutical and biotechnology corporation, founded in 1849 and is headquartered in Williamsburgh, New York. It operates to over 181 countries. Arena Pharmaceuticals was acquired by US pharmaceutical and biotechnology corporation Pfizer in March 2022 for an unknown amount. Arena Pharmaceuticals brings Pfizer a diverse pipeline of development-stage therapeutic candidates in dermatology, gastroenterology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator being developed for immuno-inflammatory diseases like Crohn's disease, ulcerative colitis, atopic dermatitis, eosinophilic esophagitis, and alopecia.

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK- an acronym from its former name GlaxoSmithKline          plc,) is a British multinational pharmaceutical company, founded in 2000 with global headquarters in London, England. It operates in 160 national markets. Brexafemme (ibrexafungerp tablets), a US-approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and for lowering the incidence of recurrent VVC (RVVC), was the subject of an exclusive license deal between GSK PLC and SCYNEXIS, INC. in March 2023.

Johnson & Johnson Services Inc.

Johnson & Johnson Services Inc is a subsidiary of Johnson & Johnson and it carries out the products that provide consumer healthcare products. It was founded in 1886 and headquartered in New Jersey, the US. It operates in 60 countries.

Merck & Company, Inc.

Merck & Company, Inc. is an American multinational pharmaceutical company and is named for Merck Group, was founded in 1668, and headquartered in  New Jersey, United States. It operates in 66 countries. Merck will purchase Prometheus Biosciences, Inc. (Prometheus) through a subsidiary on April 16, 2023, for $200 per share in cash and $10.8 billion in equity. The agreement accelerates Merck's immunology expansion and diversifies its portfolio with PRA023, a novel late-stage candidate for ulcerative colitis, Crohn's disease, and other autoimmune conditions, and Prometheus' extensive data set for target discovery and precision medicine in inflammation and immunology.

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation, founded in 1996 and is headquarters at Basel, Switzerland. Novartis AG has partners in about 140 countries.

Amgen, Inc.

Amgen, Inc. is an American multinational biopharmaceutical company founded in 1980 and is headquartered in California, United States. It operates in 100 countries and has global presence. At ACR 2022, Amgen showed new studies on serious diseases that cause inflammation and bone damage. It said that clinical and real-world data from its wide range of established treatments and pipeline assets will be shared at the annual American College of Rheumatology Convergence (ACR), which took place in Philadelphia in November 2022.

AstraZeneca plc

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company, was founded in 1999 and headquartered in England, UK. It operates in 100 countries. In Feb 2023, AstraZeneca (AZN.L) said that it was ready to grow in 2023 and beyond, counting on its growing line of drugs for cancer, metabolic disorders, and rare diseases to make up for sales of COVID products that were going down.

Eli Lily and Company

Eli Lily and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. It was founded in 1876. In Dec 2022, Lilly announced its financial plans for 2023 and said it hoped to release up to four new drugs. It expects to have a strong financial and operational performance in 2023, with volume-driven revenue growth, potential launches for donanemab, mirikizumab, lebrikizumab, and pirtobrutinib, potential regulatory submissions for tirzepatide in obesity, and many other expected pipeline advancements.

AbbVie Inc.

AbbVie Inc.  is a pharmaceutical company, was founded in 2012 and headquartered in North Chicago, Illinois. . It operates in more than 70 countries.

Dr. Reddy’s Laboratories 

Dr.    Reddy’s      Laboratories is     an      Indian         multinational pharmaceutical company, founded in 1984 headquartered in Hyderabad Hyderabad, Telengana, India.It operates in 20 countries across the world. Dr. Reddy's announced in February 2023 that it had entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Mayne Pharma Group Ltd. of Salisbury, Australia.

Definition:

Anti-inflammatory drug is a drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions.